| 1 |
34920066 | Discovery of tight-binding competitive inhibitors of dipeptidyl peptidase IV. | 2022 Jan 31 |
2 |
| 2 |
35273901 | Repurposing of existing antibiotics for the treatment of diabetes mellitus. | 2022 |
2 |
| 3 |
35371018 | Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression? | 2022 |
5 |
| 4 |
32662092 | Effect of dipeptidyl peptidase-4 inhibitors on complement activation. | 2021 Mar |
1 |
| 5 |
32914379 | Gene expression profile of epithelial-mesenchymal transition mediators in papillary thyroid cancer. | 2021 May |
1 |
| 6 |
33139859 | DPP4+ exosomes in AML patients' plasma suppress proliferation of hematopoietic progenitor cells. | 2021 Jul |
3 |
| 7 |
33427376 | Phosphonic Analogs of Alanine as Acylpeptide Hydrolase Inhibitors. | 2021 Feb |
1 |
| 8 |
33603422 | Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus. | 2021 |
3 |
| 9 |
33691757 | Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. | 2021 Mar 10 |
2 |
| 10 |
33730493 | Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules. | 2021 Apr 8 |
1 |
| 11 |
34661092 | SARS-CoV-2 and diabetes: A potential therapeutic effect of dipeptidyl peptidase 4 inhibitors in diabetic patients diagnosed with COVID-19. | 2021 Dec |
2 |
| 12 |
34716325 | The serine proteases dipeptidyl-peptidase 4 and urokinase are key molecules in human and mouse scar formation. | 2021 Oct 29 |
1 |
| 13 |
32336007 | DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of COVID-19? | 2020 Nov |
2 |
| 14 |
32487805 | An expanded role for dipeptidyl peptidase 4 in cell regulation. | 2020 Jul |
2 |
| 15 |
32661206 | Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human. | 2020 |
1 |
| 16 |
32948146 | Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases. | 2020 Sep 18 |
2 |
| 17 |
32998057 | Dipeptidyl peptidase-4 and GLP-1 interplay in STC-1 and GLUTag cell lines. | 2020 Dec |
1 |
| 18 |
29806214 | Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection. | 2019 Jan |
2 |
| 19 |
30862104 | Discovery of Galangin as a Potential DPP-4 Inhibitor That Improves Insulin-Stimulated Skeletal Muscle Glucose Uptake: A Combinational Therapy for Diabetes. | 2019 Mar 11 |
1 |
| 20 |
31357088 | CD26 in autoimmune diseases: The other side of "moonlight protein". | 2019 Oct |
2 |
| 21 |
20406072 | B-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications. | 2010 Apr |
1 |
| 22 |
20942971 | Interaction of human dipeptidyl peptidase IV and human immunodeficiency virus type-1 transcription transactivator in Sf9 cells. | 2010 Oct 13 |
1 |
| 23 |
19327104 | Dipeptidyl-peptidase IV and B-type natriuretic peptide. From bench to bedside. | 2009 |
1 |
| 24 |
18227430 | Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation. | 2008 Feb |
1 |
| 25 |
17884461 | Enzymes as a special class of therapeutic target: clinical drugs and modes of action. | 2007 Dec |
1 |
| 26 |
16364232 | Mechanism of Gly-Pro-pNA cleavage catalyzed by dipeptidyl peptidase-IV and its inhibition by saxagliptin (BMS-477118). | 2006 Jan 1 |
2 |
| 27 |
16622717 | T-cell activation via CD26 and caveolin-1 in rheumatoid synovium. | 2006 |
1 |
| 28 |
15476821 | Structure of a human A-type potassium channel interacting protein DPPX, a member of the dipeptidyl aminopeptidase family. | 2004 Oct 29 |
2 |
| 29 |
12525257 | Improved biological activity of Gly2- and Ser2-substituted analogues of glucose-dependent insulinotrophic polypeptide. | 2003 Jan |
1 |
| 30 |
12459266 | Identification and characterization of human DPP9, a novel homologue of dipeptidyl peptidase IV. | 2002 Oct 16 |
1 |
| 31 |
10567372 | Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase. | 1999 Nov 26 |
2 |
| 32 |
10570924 | Two highly conserved glutamic acid residues in the predicted beta propeller domain of dipeptidyl peptidase IV are required for its enzyme activity. | 1999 Sep 24 |
1 |
| 33 |
9685737 | Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence. | 1998 Aug |
1 |
| 34 |
8951616 | Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties. | 1996 |
3 |
| 35 |
7509871 | Peptidyl ammonium methyl ketones as substrate analog inhibitors of proline-specific peptidases. | 1993 |
2 |
| 36 |
8100523 | Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. | 1993 Jun 15 |
1 |
| 37 |
1459244 | Identification of the active site serine of the X-prolyl dipeptidyl aminopeptidase from Lactococcus lactis. | 1992 Dec 14 |
1 |
| 38 |
2580948 | Substance P in human plasma is degraded by dipeptidyl peptidase IV, not by cholinesterase. | 1985 May |
1 |